BioInvent International AB (publ)

kr 2.49As of Sun 8 Nov 2026, 12:00 UTC
STO:BINVHealthcare
Country Sweden
PE (Fwd) •••
TSR 10Y CAGR (26.68%)
Div yield —
ROE (110.15%)
Biotechnology
Beta (5Y) 0.10
PE TTM —
TSR TTM (92.18%)
Mkt cap kr 163.9M
ROIC (67.87%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 2.71
8.86%
(64.23%)
Hold 6|11|11|5|12
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.06
0.06
0.06
0.06
13.71%
15.83%
17.20%
11.59%
Revenuekr M
18.16
17.70
18.10
17.97
9.84%
2.19%
4.37%
1.96%
Peers (US$16.57M)
Cap (US$)
PE
16.67M
—
Capital
TTM
5Y
10Y
Leveragex
0.896
1.318
1.136
EBIT/Intx
1.610
0.339
0.347
Own earn%
(121.54)
(168.42)
(146.28)
Sh yield%
10.68
36.23
36.66
Owners
Insiders/Inst%
3.51
64.34
Short interest%
4.19
SBC / revenue%
4.20
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
16–18
$1 testx
−0.1
Incr. ROIC%
4